Childhood Absence Epilepsy
📧 Sign up to get email alerts when something new happens for Childhood Absence Epilepsy.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-08-04Clinical Trial Update: A Study to Evaluate the Efficacy, Safety, and Tolerability of Brivaracetam as Monotherapy in Patients 2 to 25 Years of Age With Childhood Absence Epilepsy or Juvenile Absence Epilepsy [Phase 3]
Phase 3 trial evaluating brivaracetam as monotherapy in children aged 2–25 with Childhood Absence Epilepsy or Juvenile Absence Epilepsy has …
-
CLINICAL_TRIALS trial_result · 2026-07-31Clinical Trial Update: A Study to Evaluate the Efficacy, Safety, and Tolerability of Brivaracetam as Monotherapy in Patients 2 to 25 Years of Age With Childhood Absence Epilepsy or Juvenile Absence Epilepsy [Phase 3]
Phase 3 clinical trial evaluating brivaracetam as monotherapy in children and adolescents with childhood absence epilepsy or juvenile absenc…
-
CLINICAL_TRIALS trial_result · 2026-07-23Clinical Trial Update: A Study to Evaluate the Efficacy, Safety, and Tolerability of Brivaracetam as Monotherapy in Patients 2 to 25 Years of Age With Childhood Absence Epilepsy or Juvenile Absence Epilepsy [Phase 3]
Phase 3 trial evaluating brivaracetam as monotherapy in children and adolescents with childhood absence epilepsy or juvenile absence epileps…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: A Study to Test the Long-term Safety and Tolerability of Brivaracetam in Study Participants With Childhood Absence Epilepsy or Juvenile Absence Epilepsy [Phase 3]
Clinical trial update notes a Phase 3 study evaluating the long-term safety and tolerability of brivaracetam in children with Childhood abse…
-
CLINICAL_TRIALS research · 2026-03-13Clinical Trial Update: A Study to Evaluate the Efficacy, Safety, and Tolerability of Brivaracetam as Monotherapy in Patients 2 to 25 Years of Age With Childhood Absence Epilepsy or Juvenile Absence Epilepsy [Phase 3]
Phase 3 study evaluating brivaracetam as monotherapy in children and young adults with Childhood Absence Epilepsy or Juvenile Absence Epilep…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-10-15Clinical Trial Update: Detecting Absence Seizures Using Hyperventilation and Eye Movement Recordings
A completed clinical trial evaluating detection of absence seizures using hyperventilation and eye movement recordings, sponsored by Eysz, I…
-
CLINICAL_TRIALS trial_result · 2025-10-15Clinical Trial Update: Assessing Comorbidities in Epilepsy Using Eye Movement Recordings
A completed clinical trial update examining comorbidities in epilepsy using eye movement recordings, with a focus on childhood absence epile…
-
CLINICAL_TRIALS trial_result · 2025-10-07Clinical Trial Update: A Study to Test the Long-term Safety, Tolerability and Efficacy of Brivaracetam in Study Participants 2 to 26 Years of Age With Childhood Absence Epilepsy or Juvenile Absence Epilepsy [Phase 3]
A Phase 3 trial evaluating long-term safety, tolerability, and efficacy of brivaracetam in children aged 2 to 26 years with childhood absenc…
-
CLINICAL_TRIALS trial_result · 2023-07-21Clinical Trial Update: Cannabidiol Oral Solution in Pediatric Participants With Treatment-Resistant Childhood Absence Seizures [Phase 2]
Phase 2 trial of cannabidiol oral solution in pediatric participants with treatment-resistant childhood absence seizures was terminated; res…
-
CLINICAL_TRIALS trial_result · 2023-06-18Clinical Trial Update: Long-Term Safety of Pharmaceutical Grade Synthetic Cannabidiol Oral Solution in Pediatric Participants With Treatment-Resistant Childhood Absence Seizures [Phase 2]
Phase 2 trial update on long-term safety of pharmaceutical-grade synthetic cannabidiol oral solution in pediatric patients with treatment-re…
-
CLINICAL_TRIALS trial_result · 2020-10-14Clinical Trial Update: Childhood Absence Epilepsy Rx PK-PD-Pharmacogenetics Study [Phase 3]
Phase 3 clinical trial update for a pediatric epilepsy study focusing on pharmacokinetics, pharmacodynamics, and pharmacogenetics in Childho…
-
CLINICAL_TRIALS research · 2016-06-01Clinical Trial Update: Search for Genes Influencing Childhood Absence Epilepsy (CAE) Study
Completed clinical trial investigating genetic factors influencing childhood absence epilepsy. The study aimed to identify genes associated …
-
CLINICAL_TRIALS research · 2016-01-26Clinical Trial Update: Why Are Patients With Absence Seizures Absent? A Brain Imaging Study
A completed Yale University brain-imaging study investigates brain mechanisms behind absence seizures in Childhood Absence Epilepsy.
-
CLINICAL_TRIALS trial_result · 2011-07-28Clinical Trial Update: A Pilot Study of Efficacy and Tolerability of Levetiracetam Monotherapy in Subjects With Childhood Absence Epilepsy [NA]
A completed pilot study evaluated the efficacy and tolerability of levetiracetam as monotherapy in children with childhood absence epilepsy.
-
CLINICAL_TRIALS trial_result · 2011-06-10Clinical Trial Update: A Pilot Study of Topiramate in Childhood Absence Epilepsy [Phase 2]
A Phase 2 pilot study evaluating topiramate for childhood absence epilepsy has completed.
-
CLINICAL_TRIALS trial_result · 2011-05-02Clinical Trial Update: Functional Magnetic Resonance Imaging (fMRI) Study of Memory in Children
A completed functional MRI study investigated memory in children with childhood absence epilepsy to explore neural correlates of memory.